SynthesisFrontiers in endocrinology2020

Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.

Yoon Ji Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.